Former White House advisor says the US 'would already have modified vaccines' to deal with Omicron variant if Trump were still president
- A former
White Houseadvisor said new vaccines would already be in place to curb Omicron's spread if Trump were still in office.
- Omicron might spread easily and be resistant to vaccines because of its many mutations.
Former White House advisor Stephen Miller claimed that there would already be updated
"If President Trump was still in office, by the way, we'd already have modified vaccines to deal with the new variant," Miller said, speaking to Sean Hannity on Friday night.
Scientists first detected the new Omicron variant in South Africa. It has since spread to several other countries, including Israel and Belgium, prompting a spate of travel restrictions across Europe, Asia, and North America, Insider's Aria Bendix reported. A
The variant itself has multiple mutations that might make it easier for it to evade antibodies that developed in the body after receiving a COVID-19 vaccine. The mutations might also cause the variant to spread easily — even among vaccinated people. Because of the numerous mutations, the World Health Organization has labeled Omicron a "variant of concern," a distinction given to the most threatening
It's not clear yet whether existing COVID-19 vaccines will protect against the variant. But vaccine manufacturers in the US already considering their options.
Pfizer, for example, said it will be able to manufacture and distribute an updated version of its COVID-19 vaccine within 100 days if Omicron is found to be resistant to its current vaccine. The company expects to know within two weeks whether the variant is resistant to its current vaccine, a company spokesperson told Reuters.
In his interview, Miller did not specify how Trump would have sped up the timelines proposed by Pfizer and other vaccine manufacturers like Moderna.
It's also unclear what effect Trump specifically would have on the updated vaccine progress that President Joe Biden wouldn't have. Both Pfizer and Moderna indicated they would know whether the Omicron variant is resistant to their current vaccines within the next couple weeks. Johnson & Johnson is also conducting testing.
- Richest entrepreneurs under 40 named in the IIFL Wealth Hurun list became more richer by 12% in last one year
- Time taken to deliver items & returns are the key pain points for e-comm consumers
- DGCI allows Serum Institute to export malaria vaccine to UK
- Upcoming cars launching in India in October 2022
- Gurgaon-based Indifi disbursed ₹2,800 crore worth of loans to small business owners
- Tata Tiago Electric Car
- HCL Tech
- World Heart Day 2022
- Apple Tablets in Amazon Sale
- Reliance Retail
- Akash Ambani
- Amazon festival Sale
- Vinod Shantilal Adani
- Amazon Festival Sale
- Accenture earnings forecast
- India's Richest People
- Best 5G Smartphone
- Upcoming Smartphone in 2022
- Top 10 Colleges in India
- Top 10 Airlines in World